Prevalence of HIV, HCV, and High-Risk behaviors for substance users in drop in centers in southern Iran

Journal of Addiction Medicine

Volumn 9, Issue 3, 2015, Pages 181-187

  Salehi, Alireza ^a   Naghshvarian, Mojtaba ^a   Marzban, Maryam ^a   Lankarani, Kamran Bagheri ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Drop in Center; drug user; HCV; HIV; Iran

Indexed keywords

DIAMORPHINE; METHAMPHETAMINE; NORGESIC; OPIATE;

ADULT; ARTICLE; CONTROLLED STUDY; COUNSELING; DISEASE ASSOCIATION; DROP IN CENTER; FEMALE; HEALTH BEHAVIOR; HEALTH CARE ORGANIZATION; HEALTH CARE SYSTEM; HEALTH EDUCATION; HEPATITIS C; HIGH RISK BEHAVIOR; HOMELESSNESS; HOUSING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEEDLE; PREVALENCE; PRIORITY JOURNAL; PROSTITUTION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL HEALTH; SOCIAL PROBLEM; SUBSTANCE ABUSE; COINFECTION; COMPLICATION; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; HIV INFECTIONS; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; UNSAFE SEX; YOUNG ADULT;

ADULT; COINFECTION; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; IRAN; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; UNSAFE SEX; YOUNG ADULT;

EID: 84942812639     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0000000000000112     Document Type: Article

References (37)

1. Amundsen EJ, Eskild A, Stigum H, et al. Legal access to needles and syringes/needle exchange programmes versus HIV counseling and testing to prevent transmission of HIV among intravenous drug users: A comparative study of Denmark, Norway and Sweden. Eur J Public Health 2003;13:252-258.
2. Ardebili MA, Rayejian M. Norooz Project a joint document in control of drugs, between the Islamic Republic of Iran and the Office of the United Nations Drug Control (English translated). Available at: http://dchq.ir/html/index. php. Published 1999. Accessed August 2013.
3. Avecina, Ghanoon (English translated). Sharafkandi Translate. Tehran, Iran: Soroush Publication; 1997.
4. Azim T, Chowdhury EI, Reza M, et al. Vulnerability to HIV infection among sex worker and non-sex worker female injecting drug users in Dhaka, Bangladesh: evidence from the baseline survey of a cohort study. Harm Reduct J 2006;3:33.
5. Baneshi MR, Faramarzi H, Marzban M. Prevention of disease complications through diagnostic models: how to tackle the problem of missing data? Iran J Public Health 2012;41(1):66-72.
6. Battjes RJ, Leukefeld CG, Pickens RW. Age at first injection and HIV risk among intravenous drug users. Am J Drug Alcohol Abuse 1992;18:263-273.
7. Bruandet A, Lucidarme D, Decoster A, et al. Incidence and risk factors of HCV infection in a cohort of intravenous drug users in the North and East of France (English translated). Rev Epidemiol Sante Publique 2006;54:1.
8. Dolan K, Salimi S, Nassirimanesh B, et al. Six-month follow-up of Iranian women in methadone treatment: drug use, social functioning, crime, and HIV and HCV seroincidence. Subst Abuse 2012;3:37-43.
9. Emmanuelli J. Harmreduction policy related to drug use: The needles exchange programs. Med Sci 2004;5:20.
10. Falahi H. UNAIDS/UNICEF/WHO. Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections-Islamic Republic of Iran. Ministry of Health Publication; 2004.
11. Falahi H. National AIDS Committee Secretariat, Ministry of Health andMedical Education. Islamic Republic of Iran country report on Monitoring of the United Nations General Assembly Special Session on HIV and AIDS (English translated). Tehran, Iran: Ministry of Health Publication; 2010. Available at: http://www. unaids. rg/en/dataanalysis.
12. Fedotov Y. World Drug Report 2012. UNODC United Nations Publication Sales No; 2012:E.12.XI.
13. Gough E, Kempf MC, Graham L, et al. HIV and hepatitis B and C incidence rates in US correctional populations and high risk groups: A systematic review and meta-Analysis. BMC Public Health 2010;10:777-787.
14. Hakim ED. Resaleh Afyoniyeh (English translated). Tehran, Iran: Almae Publication 2009.
15. Hagan H, Jarlais DCD. HIV and HCV infection among injecting drug users. Mt Sinai J Med 2000;67:423-428.
16. Hamid Gh. Cooperation with the International Narcotics Control Board (INCB) cooperation and interaction in implementing provisions of the three UN conventions (English translated). Available at: http://www.incb.org. Published 1998.
17. Khalitash A, Majdzadeh SR, Ehterami M. Surveys of public participation policy regarding the use of harm reduction programs for drug (English translated). Hakim J 2009;12:64-54.
18. Khosravi ANF, Rahbar MR, Motlagh ME, et al. Health Indicators in Iran. Tehran, Iran: Publication of Ministry of Health and Education in Iran; 2010;1:5-150. (in Persian).
19. Kumpfer KL, Alvarado R, Whiteside HO. Family-based interventions for substance use and misuse prevention. Subst Use Misuse 2003;38:1759-1787.
20. Lin P, Fan Z, Yang F, et al. Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China. Chin J Prev Med 2004;38:305.
21. Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet (Lond, Engl) 2008;372:1733-1745.
22. Moayed AS. Report of Ministry of Health and Education Science (English translated). Available at: http://www.behdasht.gov.ir. Published 2011.
23. Mohamad K, Majlesi F, Namdari H, et al. Depending on the cause of harm reduction for injection drug users under DIC Kermanshah province (English translated). J Public Health Med Sci 2009;1:11-22.
24. Najar M. General policies regarding the system of Narcotics, the Supreme (English translated). Leader statement Web site. Available at: www.dchq. qir. Published 2009.
25. Najar M. Report of Center for Drugebattl (English translated). Available at: http://www.dchq.ir/images/AMALKARD/amalkarddchq.pdf. Published 2011.
26. Narenjiha H, Nouri R, Akbarian M, et al. The experience of life time non-fatal overdose of drugs in Iranian substance abusers (English translated). Iran J Psychiatry Clin Psychol 2010;15:327-333.
27. Osmani ZA, Najjar MM, Zahir AM. Border Project Between the Islamic Republic of Iran, Pakistan and UNDCP triangular Initiative (English translated). Available at: http://www.undoc.org. Published 1998.
28. Rafati M, Ghotbi M, Ahmadnia H. Principles of Care for Non Communicable Disease. Tehran, Iran: Publication of Ministry of Health and Education in Iran; 2008;1:177-186.
29. Rahimimohavghar RM. 30 years trend in drug abuse situation in Iran (English translated). Hakim Res J 2002;5:171-181.
30. Sadock BJ, Sadock VA. Kaplan and Sadocks Concise Textbook of Clinical Psychiatry. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
31. Shakeri AH. Britains Historic Role in the Promotion of Drug (English translated). Tehran, Iran: Gotenberg; 2008.
32. Slesnick N, Glassman M, Garren R, et al. How to open and sustain a drop-in center for homeless youth. Child Youth Serv Rev 2008;7:727-734.
33. Stoicescu C. The Global State of HarmReduction 2012 Towards an Integrated Response. London, United Kingdom:HarmReduction International; 2012.
34. Vazirian M, Nassirimanesh B, Zamani S, et al. Needle and syringe sharing practices of injecting drug users participating in an outreach HIV prevention program in Tehran, Iran: A cross-sectional study. Harm Reduct J 2005;2:19.
35. Wood E, Spittal P, Li K, et al. Inability to access addiction treatment and risk of HIV infection among injection drug users. J Acquir Immune Defici Syndr 2004;36:750-754.
36. Yuet W. Substance abuse and developments in harm reduction. Can Med Assoc J 2000;162:697-700.
37. Zamani S. Integrated Bio-Behavioral Surveillance for HIV Infection Among Injecting Drug Users in Iran (English translated). Tehran, Iran: Ministry of Health and Medical Education Publication; 2008.